Today: ifo-Chef: Aufschwung auf wackeligen Beinen | Biontech-Gründer vor Neustart

Leading economic researchers are significantly raising their outlook: Instead of predicting a 0.6% growth rate for the current year, they now forecast 1.3%. For 2027, they expect a modest 1.1%. This improvement is attributed to increased exports to other EU countries. In line with this, the current ifo business climate index - a survey of 9,000 business leaders considered the key sentiment gauge for the German economy - showed improvement in September.

However, Clemens Fuest, president of the ifo Institute, expresses doubts during a podcast: "It is not an independent recovery. It is an expensive recovery."

Moreover, BioNTech co-founders Uğur Şahin and Özlem Türeci plan to relaunch their company Arife, but his separation from BioNTech is causing controversy. The issue revolves around patents, money, and the future of employees. Handelsblatt volunteer Dasdin Duman discusses this with Handelsblatt pharma reporter Helena Smolak. "Expropriation of one's own company" - a scandal involving vaccine pioneers.